Recent trends in financings and investor positivity indicate a positive upward trend in biotech, says Hartaj Singh, Managing Director and Senior Biotechnology Analyst, Oppenheimer. His three picks are: REGN, Nasdaq – Regeneron Pharmaceuticals, PT US$1,125, UTHR, Nasdaq – United Therapeutics Corporation, PT US$375, and BMEA, Nasdaq – Biomea Fusion PT US$70
Hot Picks: Three biotech stocks to consider for your portfolio – Video
Categories